Presenter Speech
Alexei Gogolev (Analysts)
Hello, everyone. My name is Alexei Gogolev, Head of Vertical SaaS and Health Tech Equity Research here at JPMorgan. And today, I'm delighted to have Veeva's
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 195.49 USD | -0.29% |
|
+7.41% | -12.43% |
| 03-05 | UBS Adjusts Price Target on Veeva Systems to $220 From $200, Maintains Neutral Rating | MT |
| 03-05 | RBC Adjusts Price Target on Veeva Systems to $275 From $330, Maintains Outperform Rating | MT |
Published on 01/14/2026 at 01:05 am GMT
Presenter Speech
Alexei Gogolev (Analysts)
Hello, everyone. My name is Alexei Gogolev, Head of Vertical SaaS and Health Tech Equity Research here at JPMorgan. And today, I'm delighted to have Veeva's
Select your edition
All financial news and data tailored to specific country editions